✦ LIBER ✦

PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA

✍ Scribed by P. Davey; N. Rajan; Y. Kanivets; H. Barraclough; M. Orlando; A.J. Brnabic; B. Han

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN82 COST COMPARISON OF BEVACIZUMAB PLU

✍ HG Bischoff; A Hermes; DF Heigener; S Cesaro-Tadic; S Walzer; M Nuijten 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN30 THE COSTS OF TREATING PATIENTS WIT

✍ M Nuijten 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PCN87 A COST-EFFECTIVENESS ANALYSIS OF B

✍ HG Bischoff; D Heigener; C Wiesner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN41 COST-SAVINGS ASSOCIATED WITH BEVAC

✍ D Heigener; HG Bischoff; C Wiesner; R Aultman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PCN29 THE COST SAVINGS ASSOCIATED WITH B

✍ M Nuijten; C Chouaid; A Vergnenegre 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

An indirect comparison of bevacizumab pl

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB